iCo Therapeutics Inc (CVE:ICO)’s share price dropped 5.3% during mid-day trading on Thursday . The company traded as low as C$0.09 and last traded at C$0.09. Approximately 250,537 shares traded hands during trading, a decline of 64% from the average daily volume of 692,418 shares. The stock had previously closed at C$0.10.
The company has a market capitalization of $10.65 million and a price-to-earnings ratio of -4.50.
WARNING: “iCo Therapeutics (ICO) Shares Down 5.3%” was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.baseballdailydigest.com/news/2019/03/14/ico-therapeutics-ico-shares-down-5-3.html.
iCo Therapeutics Company Profile (CVE:ICO)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
Recommended Story: Stochastic Momentum Index (SMI)
Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.